Topoisomerase II{alpha} amplification does not predict benefit from dose-intense cyclophosphamide, doxorubicin, and fluorouracil therapy in HER2-amplified early breast cancer: results of CALGB 8541/150013 (Q37163481)
Jump to navigation
Jump to search
scientific article published on 26 May 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Topoisomerase II{alpha} amplification does not predict benefit from dose-intense cyclophosphamide, doxorubicin, and fluorouracil therapy in HER2-amplified early breast cancer: results of CALGB 8541/150013 |
scientific article published on 26 May 2009 |
Statements
1 reference
Topoisomerase II{alpha} amplification does not predict benefit from dose-intense cyclophosphamide, doxorubicin, and fluorouracil therapy in HER2-amplified early breast cancer: results of CALGB 8541/150013 (English)
1 reference
Gloria Broadwater
1 reference
Constance T Cirrincione
1 reference
Eric P Winer
1 reference
Ann D Thor
1 reference
Clifford A Hudis
1 reference
Lyndsay N Harris
1 reference
Maysa Abu-Khalaf
1 reference
David Cowan
1 reference
Daniel Budman
1 reference
Donald A Berry
1 reference
Daniel F Hayes
1 reference
Paula Friedman
1 reference
Matthew Ellis
1 reference
Lynn Dressler
1 reference
26 May 2009
1 reference
1 reference
3430-3436
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference